CONSERVATIVE THERAPY IN MYOCARDIAL INFARCTION: THE IMPACT OF GENETIC FACTORS
Recently, myocardial infarction is a significant medical and social problem. Mortality in one year after infarction remains high, regardless the therapy with all recommended for the prognosis improvement medications. As one of probable reasons for adverse prognosis could be considered drug tolerance...
Main Author: | M. V. Solodun |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2016-03-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/745 |
Similar Items
-
ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE
by: M. V. Solodun, et al.
Published: (2015-09-01) -
The gene polymorphism of beta1-adrenoreceptor, postinfarction myocardial remodeling and cardiovascular risk: is there any correlation?
by: S. S. Yakushin, et al.
Published: (2018-04-01) -
Role of genetic polymorphisms associated with lipid disorders and arterial hypertension in the assessment of clinical severity and in-hospital prognosis in patients with ST-segment elevation myocardial infarction
by: A. A. Inozemtseva, et al.
Published: (2015-12-01) -
Reassessing the clinical significance of electrocardiographically unrecognized myocardial infarctions: Radionuclide infarct size and its impact on long‐term prognosis
by: Khawaja Afzal Ammar, et al.
Published: (2023-11-01) -
Biochemical Association of MTHFR C677T Polymorphism with Myocardial Infarction in the Presence of Diabetes Mellitus as a Risk Factor
by: Tauqeer Hussain Mallhi, et al.
Published: (2023-02-01)